These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 34775124)
41. Multifunctional Fe-based coordination polymer nano-bomb modified with β-lapachone and CaO Zhao P; Gong L; Chang L; Du H; Geng M; Meng S; Dai L J Nanobiotechnology; 2024 Jan; 22(1):3. PubMed ID: 38166978 [TBL] [Abstract][Full Text] [Related]
42. Tumor Microenvironment-Responsive Nanodrug for Clear-Cell Renal Cell Carcinoma Therapy via Triggering Waterfall-Like Cascade Ferroptosis. Ni W; Li Y; Liang L; Yang S; Zhan M; Lu C; Lu L; Wen L J Biomed Nanotechnol; 2022 Feb; 18(2):327-342. PubMed ID: 35484753 [TBL] [Abstract][Full Text] [Related]
43. Synergistic Amplification of Ferroptosis with Liposomal Oxidation Catalyst and Gpx4 Inhibitor for Enhanced Cancer Therapy. Yuan Y; Tian C; Wang Q; Qiu X; Wang Y; Jiang H; Hao J; He Y Adv Healthc Mater; 2023 Nov; 12(28):e2301292. PubMed ID: 37458333 [TBL] [Abstract][Full Text] [Related]
44. Improved Immune Response for Colorectal Cancer Therapy Triggered by Multifunctional Nanocomposites with Self-Amplifying Antitumor Ferroptosis. Lin X; Chen H; Deng T; Cai B; Xia Y; Xie L; Wang H; Huang C ACS Appl Mater Interfaces; 2024 Mar; 16(11):13481-13495. PubMed ID: 38456402 [TBL] [Abstract][Full Text] [Related]
45. Chemodynamic therapy combined with endogenous ferroptosis based on "sea urchin-like" copper sulfide hydrogel for enhancing anti-tumor efficacy. Li S; Wang B; Tao J; Dong Y; Wang T; Zhao X; Jiang T; Zhang L; Yang H Int J Pharm; 2024 Jul; 660():124330. PubMed ID: 38866081 [TBL] [Abstract][Full Text] [Related]
46. Enhancing Tumor Therapy of Fe(III)-Shikonin Supramolecular Nanomedicine via Triple Ferroptosis Amplification. Feng W; Shi W; Wang Z; Cui Y; Shao X; Liu S; Rong L; Liu Y; Zhang H ACS Appl Mater Interfaces; 2022 Aug; 14(33):37540-37552. PubMed ID: 35944147 [TBL] [Abstract][Full Text] [Related]
47. Fe-MnO Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713 [TBL] [Abstract][Full Text] [Related]
48. Multifunctional carbon quantum dots as a theranostic nanomedicine for fluorescence imaging-guided glutathione depletion to improve chemodynamic therapy. Li J; Hu ZE; We YJ; Liu YH; Wang N; Yu XQ J Colloid Interface Sci; 2022 Jan; 606(Pt 2):1219-1228. PubMed ID: 34492460 [TBL] [Abstract][Full Text] [Related]
49. GSH/APE1 Cascade-Activated Nanoplatform for Imaging Therapy Resistance Dynamics and Enzyme-Mediated Adaptive Ferroptosis. Yue R; Zhou M; Li X; Xu L; Lu C; Dong Z; Lei L; Liu H; Guan G; Liu Q; Zhang XB; Song G ACS Nano; 2023 Jul; 17(14):13792-13810. PubMed ID: 37458417 [TBL] [Abstract][Full Text] [Related]
50. Multifunctional Sr/Se co-doped ZIF-8 nanozyme for chemo/chemodynamic synergistic tumor therapy Wu A; Han M; Ni Z; Li H; Chen Y; Yang Z; Feng Y; He Z; Zhen H; Wang X Theranostics; 2024; 14(5):1939-1955. PubMed ID: 38505601 [No Abstract] [Full Text] [Related]
51. Enhanced photothermal-ferroptosis effects based on RBCm-coated PDA nanoparticles for effective cancer therapy. Yu H; Yan J; Li Z; Song T; Ning F; Tan J; Sun Y J Mater Chem B; 2023 Jan; 11(2):415-429. PubMed ID: 36512437 [TBL] [Abstract][Full Text] [Related]
52. Biodegradable zwitterionic polymer-cloaked defective metal-organic frameworks for ferroptosis-inducing cancer therapy. Zhang M; Yao X; Xu J; Song J; Mai S; Zhu W; Zhang Y; Zhu L; Yang W Int J Pharm; 2024 Apr; 655():124032. PubMed ID: 38521374 [TBL] [Abstract][Full Text] [Related]
53. An AND Logic Gate for Magnetic-Resonance-Imaging-Guided Ferroptosis Therapy of Tumors. Fan Q; Xiong W; Zhou H; Yang J; Feng J; Li Z; Wu L; Hu F; Duan X; Li B; Fan J; Xu Y; Chen X; Shen Z Adv Mater; 2023 Nov; 35(45):e2305932. PubMed ID: 37717205 [TBL] [Abstract][Full Text] [Related]
54. FeP-Based Nanotheranostic Platform for Enhanced Phototherapy/Ferroptosis/Chemodynamic Therapy. An N; Tang S; Wang Y; Luan J; Shi Y; Gao M; Guo C Small; 2024 Aug; 20(32):e2309940. PubMed ID: 38534030 [TBL] [Abstract][Full Text] [Related]
55. Iron-based nanoparticles for MR imaging-guided ferroptosis in combination with photodynamic therapy to enhance cancer treatment. Chen Q; Ma X; Xie L; Chen W; Xu Z; Song E; Zhu X; Song Y Nanoscale; 2021 Mar; 13(9):4855-4870. PubMed ID: 33624647 [TBL] [Abstract][Full Text] [Related]
56. Biodegradable nanoplatform upregulates tumor microenvironment acidity for enhanced cancer therapy via synergistic induction of apoptosis, ferroptosis, and anti-angiogenesis. Zhang C; Wang P; Zhang YN; Lu P; Huang X; Wang Y; Ran L; Xin H; Xu X; Gao W; Sun Y; Zhang L; Zhang G J Nanobiotechnology; 2023 Feb; 21(1):59. PubMed ID: 36810074 [TBL] [Abstract][Full Text] [Related]
57. Amplified Fenton-Based Oxidative Stress Utilizing Ultraviolet Upconversion Luminescence-Fueled Nanoreactors for Apoptosis-Strengthened Ferroptosis Anticancer Therapy. Nguyen NT; Kim J; Le XT; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS ACS Nano; 2023 Jan; 17(1):382-401. PubMed ID: 36579941 [TBL] [Abstract][Full Text] [Related]
58. Reactive Oxygen Species Amplifier for Apoptosis-Ferroptosis Mediated High-Efficiency Radiosensitization of Tumors. Wang Z; Ren X; Li Y; Qiu L; Wang D; Liu A; Liang H; Li L; Yang B; Whittaker AK; Liu Z; Jin S; Lin Q; Wang T ACS Nano; 2024 Apr; 18(14):10288-10301. PubMed ID: 38556985 [TBL] [Abstract][Full Text] [Related]
59. A strategy of "adding fuel to the flames" enables a self-accelerating cycle of ferroptosis-cuproptosis for potent antitumor therapy. Huang L; Zhu J; Wu G; Xiong W; Feng J; Yan C; Yang J; Li Z; Fan Q; Ren B; Li Y; Chen C; Yu X; Shen Z Biomaterials; 2024 Dec; 311():122701. PubMed ID: 38981152 [TBL] [Abstract][Full Text] [Related]
60. A homologous membrane-camouflaged self-assembled nanodrug for synergistic antitumor therapy. Xie X; Li Z; Tang H; Zhang Y; Huang Y; Zhang F; You Y; Xu L; Wu C; Yao Z; Peng X; Zhang Q; Li B Acta Biomater; 2024 Jul; 183():292-305. PubMed ID: 38838903 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]